CVE-2022-1521
3.2.4 IMPROPER ACCESS CONTROL CWE-284
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
3.2.4 IMPROPER ACCESS CONTROL CWE-284
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
- Record
CVE-2022-1521- CVSS 3.1
- 9.1 Critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Weakness
- CWE-284
- Updated
- 2026-11-02
EUVDEUVD-2022-24819
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
- Record
EUVD-2022-24819- CVSS 3.1
- 9.1 Critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-hgpf-hf44-725p
LRM does not implement authentication or authorization by default. A malicious actor can inject,...
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
- Record
GHSA-hgpf-hf44-725p- CVSS 3.1
- 9.1 Critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Weakness
- CWE-862
- Updated
- 2026-11-02
NVD
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
- Record
CVE-2022-1521- CVSS 3.1
- 9.1 Critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - CVSS 2.0
- 6.4 Medium
AV:N/AC:L/Au:N/C:P/I:P/A:N - Weakness
- CWE-284, CWE-306, CWE-862
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-1521 is a critical vulnerability (CVSS 9.1) in Illumina Iseq 100 Instrument, published June 24, 2022. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.14%, the 66th percentile. No source names a fixed version.